Pfizer has signed a worldwide licensing agreement, excluding China, with biopharmaceutical company 3SBio to develop, manufacture and commercialise bispecific antibody targeting programmed cell death ...

The recent run of successful equity block trades continued on Wednesday evening, with trades in cement maker Heidelberg ...

Former head of bond syndicate might just be what Bank of America needs to achieve its goal — a consistent place among the top ...

The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also ... to market ahead of a rival jab from Pfizer, which is also anticipating ...

3SBio will receive an upfront payment of $1.25B and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8B as well as tiered ...

Pfizer (NYSE:PFE) has signed an exclusive global licensing deal with China’s 3SBio for the development of its cancer drug candidate, SSGJ-707. SSGJ-707, a bispecific antibody targeting PD-1 and ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

Pfizer is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.Shares are down 19% over the past ...

Despite trading near decade-low valuations, Pfizer PFE is strategically repositioning itself for substantial long-term growth through its oncology transformation, particularly via the Seagen ...

North Carolina has pulled its economic incentive for the drug manufacturing giant Pfizer to hire hundreds of workers in the Lee County seat of Sanford. The decision Wednesday arrived three months ...